# FDA Inspection 735204 - GlaxoSmithKline Manufacturing S.p.A. - June 28, 2011

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/d4b52950-99c3-43fb-a056-563aa68d9709
Source feed: FDA_Inspections

> FDA Inspection 735204 for GlaxoSmithKline Manufacturing S.p.A. on June 28, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 735204
- Company Name: GlaxoSmithKline Manufacturing S.p.A.
- Inspection Date: 2011-06-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1285374 - 2025-05-15](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/6fee4446-b8f0-4691-a877-618dc26c742b)
- [FDA Inspection 1244033 - 2023-10-26](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/c2a4825c-c374-4a17-8122-35913c30b269)
- [FDA Inspection 1064045 - 2017-09-29](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/3e3eabdd-fb0e-4816-b71a-de1409ea4ed4)
- [FDA Inspection 982333 - 2016-07-22](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/98e8f571-5a65-40f4-9600-4b7642f7db8d)
- [FDA Inspection 934049 - 2015-05-27](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/11cd01a9-b7be-4ff7-a6b9-3b7a7148d1b7)

Company: https://www.keypedia.com/companies/glaxosmithkline-manufacturing-spa/11f7427f-c02e-4b80-91dd-f90cbe9b90a9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c